These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39356010)

  • 1. Programmed death-ligand expression and lymph node involvement in penile squamous cell carcinoma.
    Peyroteo I; Santos F; Marialva C; Brito Ramos R
    Arch Ital Urol Androl; 2024 Oct; 96(3):12856. PubMed ID: 39356010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1 and p16 Expression in Penile Squamous Cell Carcinoma From an Endemic Region.
    De Bacco MW; Carvalhal GF; MacGregor B; Marçal JMB; Wagner MB; Sonpavde GP; Fay AP
    Clin Genitourin Cancer; 2020 Jun; 18(3):e254-e259. PubMed ID: 32139302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of programmed death-ligand 1 protein expression between primary tumors and lymph node metastatic lesions in oral squamous cell carcinoma].
    Xia RH; Hu YH; Zhang CY; Xu SM; Li J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2022 Nov; 57(11):1113-1118. PubMed ID: 36379889
    [No Abstract]   [Full Text] [Related]  

  • 4. PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes.
    Davidsson S; Carlsson J; Giunchi F; Harlow A; Kirrander P; Rider J; Fiorentino M; Andrén O
    Eur Urol Oncol; 2019 Mar; 2(2):214-221. PubMed ID: 31017099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches.
    Udager AM; Liu TY; Skala SL; Magers MJ; McDaniel AS; Spratt DE; Feng FY; Siddiqui J; Cao X; Fields KL; Morgan TM; Palapattu GS; Weizer AZ; Chinnaiyan AM; Alva A; Montgomery JS; Tomlins SA; Jiang H; Mehra R
    Ann Oncol; 2016 Sep; 27(9):1706-12. PubMed ID: 27217541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 expression in bladder cancer: Which scoring algorithm in what tissue?
    Schulz GB; Todorova R; Braunschweig T; Rodler S; Volz Y; Eismann L; Pfitzinger P; Jokisch F; Buchner A; Stief C; Mayr D; Casuscelli J
    Urol Oncol; 2021 Oct; 39(10):734.e1-734.e10. PubMed ID: 34261585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nomogram incorporating PD-L1, NLR, and clinicopathologic features to predict inguinal lymph node metastasis in penile squamous cell carcinoma.
    Hu J; Li H; He T; Deng H; Gong G; Cui Y; Liu P; Ren W; Li C; Chen J; Zu X
    Urol Oncol; 2020 Jul; 38(7):641.e19-641.e29. PubMed ID: 32389428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Programmed Death Ligand 1 in Penile Cancer is of Prognostic Value and Associated with HPV Status.
    Ottenhof SR; Djajadiningrat RS; de Jong J; Thygesen HH; Horenblas S; Jordanova ES
    J Urol; 2017 Mar; 197(3 Pt 1):690-697. PubMed ID: 27697578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between PD-L1 expression and lymph node metastasis in cutaneous squamous cell carcinoma.
    Kamiya S; Kato J; Kamiya T; Yamashita T; Sumikawa Y; Hida T; Horimoto K; Sato S; Takahashi H; Sawada M; Kubo T; Torigoe T; Uhara H
    Asia Pac J Clin Oncol; 2020 Apr; 16(2):e108-e112. PubMed ID: 30411509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort.
    Cocks M; Taheri D; Ball MW; Bezerra SM; Del Carmen Rodriguez M; Ricardo BFP; Bivalacqua TJ; Sharma RB; Meeker A; Chaux A; Burnett AL; Netto GJ
    Hum Pathol; 2017 Jan; 59():55-61. PubMed ID: 27663086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the programmed death ligand-1 combined positive score in tumors and clinicopathological features in esophageal cancer.
    Huang Z; Jin Y; Cai X; Chen L; Shen X; Li B; Chen H; Li Y
    Thorac Cancer; 2022 Feb; 13(4):523-532. PubMed ID: 34953041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment.
    Hoshimoto A; Tatsuguchi A; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
    World J Gastroenterol; 2023 Oct; 29(40):5566-5581. PubMed ID: 37970475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma.
    Ottenhof SR; Djajadiningrat RS; Thygesen HH; Jakobs PJ; Jóźwiak K; Heeren AM; de Jong J; Sanders J; Horenblas S; Jordanova ES
    Front Immunol; 2018; 9():1253. PubMed ID: 29942303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of programmed cell death ligand 1 expression in a contemporary cohort of penile squamous cell carcinoma and its correlation with clinicopathologic and survival parameters: A study of 134 patients.
    Lobo A; Mishra SK; Jha S; Tiwari A; Kapoor R; Sharma S; Kaushal S; Kiranmai NS; Das MR; Peddinti KP; Sharma SK; Bhardwaj N; Arora S; Jain D; Jain E; Munjal G; Shinde S; Malik V; Singh H; Varshney J; Pradhan D; Dixit M; Pattnaik N; Sharma AK; Barapatre YR; Pradhan M; Satapathy K; Rath D; Jaiswal S; Das S; Khadenga C; Routa S; Baisakh MR; Tiwari R; Sampat NY; Chakrabarti I; Parwani AV; Mohanty SK
    Am J Clin Pathol; 2024 Jan; 161(1):49-59. PubMed ID: 37639681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
    Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of PD-L1 expression with CD8+ T cells and oxidative stress-related molecules NRF2 and NQO1 in esophageal squamous cell carcinoma.
    Zhang X; Yang Y; Zhao H; Tian Z; Cao Q; Li Y; Gu Y; Song Q; Hu X; Jin M; Jiang X
    J Pathol Clin Res; 2024 Jul; 10(4):e12390. PubMed ID: 38992928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression.
    Xu SM; Shi CJ; Xia RH; Wang LZ; Tian Z; Ye WM; Liu L; Liu SL; Zhang CY; Hu YH; Zhou R; Han Y; Wang Y; Zhang ZY; Li J
    Front Immunol; 2021; 12():798424. PubMed ID: 35145511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-1 and programmed cell death-ligand 1 in primary and lymph node metastasis lesions of non-small cell lung carcinoma.
    Yamada T; Miki Y; Suzuki M; Kondoh O; Saito-Koyama R; Ono K; Okada Y; Sasano H
    Cancer Med; 2022 Jan; 11(2):479-491. PubMed ID: 34907653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.
    Kim MY; Koh J; Kim S; Go H; Jeon YK; Chung DH
    Lung Cancer; 2015 Apr; 88(1):24-33. PubMed ID: 25662388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathological significance of PD-L1 expression assessed by the combined positive score (CPS) in head and neck squamous cell carcinoma.
    Wusiman D; Guo L; Huang Z; Li Z; Liu S; Ying J; Li W; An C
    Pathol Res Pract; 2022 Aug; 236():153934. PubMed ID: 35691098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.